ROCCO, ILARIA
 Distribuzione geografica
Continente #
EU - Europa 2.711
AS - Asia 125
NA - Nord America 18
SA - Sud America 13
AF - Africa 1
OC - Oceania 1
Totale 2.869
Nazione #
IT - Italia 2.707
SG - Singapore 50
CN - Cina 34
VN - Vietnam 33
US - Stati Uniti d'America 16
AR - Argentina 6
BR - Brasile 5
HK - Hong Kong 4
IN - India 3
RU - Federazione Russa 3
CI - Costa d'Avorio 1
EC - Ecuador 1
ID - Indonesia 1
MX - Messico 1
PA - Panama 1
PE - Perù 1
PF - Polinesia Francese 1
UA - Ucraina 1
Totale 2.869
Città #
Genova 1.645
Genoa 640
Rapallo 266
Vado Ligure 154
Singapore 11
Beijing 10
Ashburn 9
Hanoi 8
Ho Chi Minh City 8
Hong Kong 4
Biên Hòa 3
Bordighera 2
Buenos Aires 2
Haiphong 2
Vĩnh Tường 2
Abidjan 1
Araraquara 1
Atlanta 1
Belén de Escobar 1
Bhopal 1
Bắc Giang 1
Campo Bom 1
Chennai 1
Cuenca 1
Da Nang 1
Denver 1
Guernica 1
Hurlingham 1
Hải Dương 1
Kurgan 1
Lima 1
Los Angeles 1
Ludhiana 1
Melitopol 1
Mexico City 1
Nanjing 1
Nha Trang 1
Ninh Bình 1
Novosibirsk 1
Panama City 1
Papeete 1
Phoenix 1
Providence 1
San Miguel de Tucumán 1
Santa Bárbara 1
Santa Clara 1
Sidoarjo 1
Simão Dias 1
São Carlos 1
Tianjin 1
Usinsk 1
Vĩnh Long 1
Totale 2.803
Nome #
APO866 activity in hematologic malignancies: a preclinical in vitro study. 215
Abstract 49: Agreement of immunohistochemistry, fluorescence in situ hybridization, real-time quantitative polymerase-chain reaction, and quantitative reverse transcriptase PCR for Her-2/Neu status assessment in breast cancer patients: a single center, retrospective m 186
Reverse-transcriptase polymerase chain reaction of the maspin gene in the detection of bone marrow breast carcinoma cell contamination. 186
Ras-induced resistance to lapatinib is overcome by MEK inhibition 184
Effect of different cytokines on mammaglobin and maspin gene expression in normal leukocytes. possible relevance to the assays for the detection of micrometastatic breast cancer 179
Molecular diagnosis and monitoring of chronic myelogenous leukemia: BCR-Abl and more. 172
Patient-tailored treatments with anti-EGFR monoclonal antibodies in advanced colorectal cancer: KRAS and beyond. 171
ANTITUMOR ACTIVITY OF NAMPT INHIBITION AND SYNERGY WITH CYCLOSPORIN A AND HDACIS TO PROMOTE APOPTOSIS IN PRIMARY LEUKEMIC CELLS 170
Peripheral blood vs. bone marrow for molecular monitoring of BCR-ABL1 levels in chronic myelogenous leukemia, a retrospective analysis in allogeneic bone marrow recipients. 164
Tumor necrosis factor-related apoptosis-inducing ligand cooperates with anticancer drugs to overcome chemoresistance in antiapoptotic Bcl-2 family members expressing jurkat cells. 159
Hedgehog Signaling Is Useful as a Novel Molecular Marker for Predicting Relapse and Resistance During Chronic Myeloid Leukemia Treatment 156
Activation of the death receptor apoptosis pathway by TRAIL overcomes anticancer drug resisitance in antiapoptotic bcl-2 family members expressing lymphoma cells 152
Proteasome inhibitor-induced apoptosis in human monocyte-derived dendritic cells. 145
Tracking molecular relapse of chronic myeloid leukemia by measuring Hedgehog signaling status 145
Evidence for a protective role of Mcl-1 in proteasome inhibitor-induced apoptosis 141
HDAC INHIBITORS SYNERGISTICALLY ENHANCE AP0866 ACTIVITY IN HUMAN LEUKEMIA CELLS: EVIDENCE FOR CONVERGING MECHANISMS OF SIRT1 INHIBITION 133
Novel 2-[(benzylamino)methyl]pyrrolidine-3,4-diol derivatives as alpha-mannosidase inhibitors and with antitumor activities against hematological and solid malignancies. 129
Potent Synergistic Activity of the NAD plus Synthesis Inhibitor APO866 and of the Apoptosis Inducer TRAIL in in Vitro and Ex Vivo Cellular Models of Non Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia. 94
Totale 2.881
Categoria #
all - tutte 8.836
article - articoli 8.836
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.672


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021104 0 0 0 0 0 14 10 16 10 14 26 14
2021/2022265 9 33 17 40 13 10 16 59 6 16 21 25
2022/2023336 39 47 1 35 58 45 2 18 45 0 42 4
2023/2024145 5 15 0 21 7 37 5 9 6 2 9 29
2024/2025416 12 28 11 32 54 25 33 83 16 18 40 64
2025/2026327 90 15 28 54 123 17 0 0 0 0 0 0
Totale 2.881